Dingguo P. Zhang

No. 300, Guangzhou Road, 
Nanjing, CN 
No. 300, Guangzhou Road, 
Nanjing, CN 

Overview

Dingguo Zhang practices practicing medicine in Nanjing, China.

Their clinical expertise encompasses Fainting, Coronary Heart Disease, Esophageal Varices, Gastrointestinal Bleeding, and Angioplasty.

They are actively involved in clinical research, co-authoring 22 peer reviewed articles and participating in 3 clinical trials.

Locations

No. 300, Guangzhou Road, Nanjing, 210029, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Intensified Antiplatelet Therapy in Post-PCI Patients With High On-treatment Platelet Reactivity: the OPTIMA-2 Trial
Intensified Antiplatelet Therapy in Post-PCI Patients With High On-treatment Platelet Reactivity: the OPTIMA-2 Trial
Enrollment Status: Completed
Publish Date: August 18, 2020
Intervention Type: Drug
Study Phase: Phase 4
Associations of the Pharmacogenetic and Pharmacokinetic Factors With Clopidogrel Low Response and Clinical Outcome in Patients With Coronary Stent Implantation: a Registration Study
Associations of the Pharmacogenetic and Pharmacokinetic Factors With Clopidogrel Low Response and Clinical Outcome in Patients With Coronary Stent Implantation: a Registration Study
Enrollment Status: Completed
Publish Date: October 18, 2017
Reversal of the Anti-platelet Effects of Ticagrelor in Healthy Persons and Patients With Coronary Artery Disease
Reversal of the Anti-platelet Effects of Ticagrelor in Healthy Persons and Patients With Coronary Artery Disease
Enrollment Status: Completed
Publish Date: August 16, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

22 Total Publications

From Multi-Omics to Mechanism: Nucleocapsid-RCHY1-JUNB Axis Underlies SARS-CoV-2 Related Atrial Fibrillation Vulnerability.
From Multi-Omics to Mechanism: Nucleocapsid-RCHY1-JUNB Axis Underlies SARS-CoV-2 Related Atrial Fibrillation Vulnerability.
Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Published: April 26, 2026

Frequently Asked Questions about Dingguo P. Zhang

Is Dingguo P. Zhang a top-rated expert for Fainting?

MediFind is an objective health platform that identifies experts based on real-world data. Dingguo P. Zhang is classified as an Experienced expert for Fainting, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Dingguo P. Zhang participate in research or clinical trials?

Yes. Dingguo P. Zhang has published 22 articles and abstracts on conditions like Fainting. You can view a list of Dingguo P. Zhang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhang's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile